TBI Biomarkers as Indicators of Therepeutic Efficacy

TBI Biomarkers as Indicators of Therepeutic Efficacy

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Tan, Ciara Natasha

    Trial Phone: 321.841.4129

  • IRB No: 15.104.08

    Principal Investigator: Linda Papa, MD

    Sub Investigators: Giordano, Philip MD; Weber, Kurt MD; Tan, Ciara; Ameli, Neema; Lopez, Marco; Mendez Giordano, Diego I.

    Age Group: Adult

    Applicable Disease Sites: Traumatic Brain Injury

  • Objective

    The purpose of the research study is to evaluate a blood test for patients with traumatic brain injury who are being treated with the PoNS device. If it changes with treatment, it may help doctors make decisions about which treatments to use and may help researchers discover new treatments for patients with traumatic brain injury. The blood test could also help doctors determine how serious a brain injury was even years after an injury

  • Key Eligibility

    Any adult patient enrolled in TBI PoNS Study.